…
Nanalysis Scientific Corp. develops, manufactures, and sells magnetic resonance technology products in Canada, the United States, Europe, Asia, and internationally. The company operates through Scientific Equipment and Security Services segment. It offers nuclear magnetic resonance (NMR) spectrometers; magnetic resonance test, and measurement and diagnostic system; 60-NMR platform; 100-NMR platform; 60-TEACH Platform; QUAD NMR Console; and Cameleon 4 console, a compact alternative to facilitate MRI for teaching. The company also provides software products, such as NMRGui, an user interface for data acquisition and processing of benchtop NMR product; SPINit MR software platform to facilitate data acquisition, processing, and pulse programming; and NMRFx platform that offers a suite of software tools to streamline and automate MR data analysis and management. In addition, it offers security service, including preventive and on-call maintenance services, scheduled preventative maintenance work, corrective maintenance work, installation and upgrade projects for detection and general security equipment; other technical maintenance services; and installation and maintenance services for commercial security equipment, such as scanning devices, metal detectors, detection equipment, and other general security equipment. It serves pharmaceutical, biotechnology, nutraceutical, chemical, security, food, oil and gas, materials, life science, medical, and educational industries. The company is headquartered in Calgary, Canada.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Nanalysis Scientific is a Canadian maker of compact benchtop nuclear magnetic resonance (NMR) spectrometers and related analytical instruments for academic, industrial and government laboratories. Long-term growth may be supported by wider adoption of low-field benchtop NMR as a lower-cost, space-efficient alternative to high-field systems, an expanding installed base that can drive recurring service and consumables revenue, and geographic and product-line expansion. Investors may find it attractive because it appears positioned in a niche with technology-driven replacement cycles and aftermarket revenue potential.
Key investment risks include small-cap execution and financing risk, sensitivity to cyclical capital-equipment spending, competition from larger instrument makers, and supply-chain or manufacturing constraints that could pressure growth and margins.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | -5.64M | -13.63M | -16.80M | -10.40M | -1.77M |
| Net income | -5.66M | -13.61M | -16.78M | -9.91M | -1.77M |
| Selling general administrative | 10.11M | 11.29M | 12.39M | 15.02M | 8.28M |
| Gross profit | 9.96M | 12.75M | 3.97M | 11.14M | 10.24M |
| Reconciled depreciation | 3.43M | 4.63M | 4.67M | 4.65M | 2.57M |
| Ebit | - | - | - | - | -1.19M |
| Ebitda | - | - | - | -5.26M | 1.38M |
| Operating income | -3.77M | -3.44M | -13.47M | -9.91M | -1.19M |
| Interest expense | 1.37M | 1.34M | 0.28M | - | 0.00M |
| Tax provision | 0.02M | -0.02M | -0.01M | -0.48M | 0.00M |
| Interest income | - | - | - | - | 0.00M |
| Net interest income | -1.37M | -1.34M | -0.28M | -0.08M | 0.00M |
| Total revenue | 40.13M | 45.49M | 28.47M | 24.82M | 16.04M |
| Total operating expenses | 43.90M | 48.94M | 41.93M | 34.73M | 17.23M |
| Cost of revenue | 30.17M | 32.75M | 24.50M | 13.68M | 5.80M |
| Total other income expense net | -0.51M | -8.85M | -3.04M | -0.41M | -0.58M |
| Net income from continuing ops | -5.66M | -13.61M | -16.78M | -9.91M | -1.77M |
| Net income applicable to common shares | - | - | - | - | -1.77M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 38.41M | 42.37M | 53.82M | 69.90M | 37.79M |
| Intangible assets | 12.39M | 13.05M | 15.95M | 26.63M | 14.11M |
| Other current assets | 1.43M | 1.43M | 1.60M | 2.06M | - |
| Total liab | 24.99M | 26.82M | 30.34M | 22.33M | 13.83M |
| Total stockholder equity | 13.42M | 15.55M | 23.48M | 35.13M | 23.96M |
| Deferred long term liab | - | - | - | - | 12.48M |
| Other current liab | - | 0.30M | 0.43M | 0.81M | 2.01M |
| Common stock | - | - | - | - | 31.30M |
| Capital stock | 60.20M | 57.56M | 53.20M | 49.02M | 31.30M |
| Retained earnings | -54.26M | -48.60M | -34.99M | -18.79M | -9.69M |
| Other liab | - | - | - | - | 1.40M |
| Good will | 5.70M | 5.70M | 5.70M | 13.08M | 0.39M |
| Other assets | - | - | - | - | 12.48M |
| Cash | 0.55M | 1.38M | 0.76M | 3.52M | 10.40M |
| Total current liabilities | 17.20M | 14.38M | 14.60M | 13.51M | 8.65M |
| Net debt | 15.45M | 14.78M | 18.29M | 3.92M | - |
| Short long term debt | 9.79M | 6.01M | 6.49M | 3.65M | 1.94M |
| Other stockholder equity | - | - | - | - | 0.71M |
| Property plant equipment | - | - | - | - | 2.54M |
| Total current assets | 16.73M | 18.26M | 17.91M | 21.95M | 20.76M |
| Long term investments | - | 0.00M | 5.73M | - | - |
| Net tangible assets | - | - | - | - | 21.95M |
| Net receivables | 7.39M | 9.92M | 8.33M | 6.08M | 6.10M |
| Long term debt | 6.20M | 10.14M | 12.56M | 3.79M | 2.75M |
| Inventory | 3.65M | 4.39M | 5.79M | 7.39M | 3.68M |
| Accounts payable | 5.20M | 5.83M | 5.08M | 5.76M | 4.44M |
| Non currrent assets other | 1.30M | 2.13M | 3.11M | 0.94M | - |
| Non current assets total | 21.68M | 24.11M | 35.91M | 47.95M | 17.03M |
| Capital lease obligations | 1.59M | 2.20M | 2.92M | 3.31M | 1.30M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | - | -1.69M | 0.00M | -11.73M | -3.35M |
| Change to liabilities | - | - | - | - | 0.00M |
| Total cashflows from investing activities | - | - | - | - | -3.35M |
| Net borrowings | -1.41M | -4.17M | 11.57M | - | 1.17M |
| Total cash from financing activities | 0.11M | -0.96M | 14.48M | 13.21M | 11.79M |
| Change to operating activities | - | - | - | - | -2.56M |
| Net income | -5.66M | -13.61M | -16.78M | -9.91M | -1.77M |
| Change in cash | 1.78M | 0.62M | -2.77M | -6.88M | 7.25M |
| Begin period cash flow | 1.38M | 0.76M | 3.52M | 10.40M | 3.16M |
| End period cash flow | 3.16M | 1.38M | 0.76M | 3.52M | 10.40M |
| Total cash from operating activities | 3.45M | 3.26M | -11.19M | -8.36M | -1.20M |
| Depreciation | 3.43M | 4.63M | 4.67M | 4.65M | 0.86M |
| Dividends paid | 0.00M | 0.00M | 0.00M | 0.00M | - |
| Change to inventory | 0.74M | 1.42M | 0.82M | - | - |
| Other cashflows from financing activities | - | - | - | - | 0.00M |
| Change to netincome | - | - | - | - | 0.57M |
| Capital expenditures | 1.88M | 1.86M | 4.59M | 7.20M | 0.59M |
| Change in working capital | 3.73M | 1.26M | -2.92M | -4.88M | -2.56M |
| Stock based compensation | 0.40M | 1.03M | 1.05M | 1.56M | 0.59M |
| Other non cash items | 1.58M | 1.62M | -0.51M | 0.15M | -0.02M |
| Free cash flow | 1.57M | 1.41M | -15.78M | -15.56M | -4.20M |
Sector: Technology Industry: Scientific & Technical Instruments
|
Stock Name
|
Change
(CAD) |
Price
(CAD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| NSCI Nanalysis Scientific Corp |
0.01 4.35% |
0.12 | - | 21.74 | 0.51 | 1.33 | 0.87 | -31.02 |
| PNG Kraken Robotics Inc |
-0.20 5.30% |
3.57 | 817.00 | 125.00 | 24.55 | 11.20 | 25.43 | 163.15 |
| PALS Paragon Advanced Labs Inc. |
- -% |
2.20 | - | - | 16.83 | - | - | - |
| EDY Eddy Smart Home Solutions Ltd |
0.01 0.67% |
1.51 | - | - | 2.32 | 0.79 | 2.44 | -2.14 |
| JTC JEMTEC Inc |
- -% |
1.27 | 16.86 | - | 1.73 | 1.25 | 0.44 | 2.33 |
Nanalysis Scientific Corp. develops, manufactures, and sells magnetic resonance technology products in Canada, the United States, Europe, Asia, and internationally. The company operates through Scientific Equipment and Security Services segment. It offers nuclear magnetic resonance (NMR) spectrometers; magnetic resonance test, and measurement and diagnostic system; 60-NMR platform; 100-NMR platform; 60-TEACH Platform; QUAD NMR Console; and Cameleon 4 console, a compact alternative to facilitate MRI for teaching. The company also provides software products, such as NMRGui, an user interface for data acquisition and processing of benchtop NMR product; SPINit MR software platform to facilitate data acquisition, processing, and pulse programming; and NMRFx platform that offers a suite of software tools to streamline and automate MR data analysis and management. In addition, it offers security service, including preventive and on-call maintenance services, scheduled preventative maintenance work, corrective maintenance work, installation and upgrade projects for detection and general security equipment; other technical maintenance services; and installation and maintenance services for commercial security equipment, such as scanning devices, metal detectors, detection equipment, and other general security equipment. It serves pharmaceutical, biotechnology, nutraceutical, chemical, security, food, oil and gas, materials, life science, medical, and educational industries. The company is headquartered in Calgary, Canada.
| Name | Title | Year Born |
|---|---|---|
| Mr. Martin Andrew Burian CPA, CA, CPA | Corp. Sec. & Independent Chairman | 1964 |
| Mr. Sean Krakiwsky M.Sc. | Founder, CEO, Pres & Director | 1970 |
| Mr. Julien Muller | Chief Technology Officer | NA |
| Mr. Randall McRae C.A., CPA | Corp. Controller & Interim CFO | NA |
| Dr. Heather Phillips | Director of Operations | NA |
| Mr. Matthew Selinger | Investor Relations Mang. | NA |
| Dr. Matt Zamora | Sales Mang. | NA |
| Dr. Susanne Riegel | Director of Marketing & Product Mang. | NA |
| Dr. Greg McFeetors | Head of Manufacturing | NA |
| Mr. Sean Krakiwsky M.Sc. | Founder, CEO, President & Director | 1970 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.